CLINICAL_TRIALS
trial_result
· 2020-07-02
Clinical Trial Update: Preservative-free Tafluprost Eye Drops in Newly Diagnosed Patients With Glaucoma [Phase 2, Phase 3]
Summary
Phase 2/3 trial updates on preservative-free tafluprost eye drops for newly diagnosed glaucoma patients have been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alexandria University | Conditions: Glaucoma | Phase 2, Phase 3 | Status: COMPLETED